Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 12:26 AM
NCT ID: NCT02576860
Description: None
Frequency Threshold: 2
Time Frame: 115 Days
Study: NCT02576860
Study Brief: Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Treatment CLS001 (Omignan) gel applied once daily CLS001 (Omiganan): Topical gel 0 None 1 136 47 136 View
Vehicle Gel Vehicle gel applied once daily Vehicle: Vehicle gel 0 None 0 127 36 127 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Salmonellosis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 20 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Viral upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 20 View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 20 View
Bronchitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 20 View
Sinusitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA Ver. 20 View
Application site pain NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 20 View
Application site erythema NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 20 View
Application site pruritus NON_SYSTEMATIC_ASSESSMENT General disorders MedDRA Ver. 20 View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA Ver. 20 View
Rosacea NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA Ver. 20 View
Cough NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA Ver. 20 View